NEURESCUE Device as an Adjunct to In-Hospital Cardiac Arrest (ARISE)

Description

The NEURESCUE device is the first intelligent catheter for aortic balloon occlusion, an emergency technique that supercharges blood flow to the heart and brain within one minute from deployment. The catheter-based device is delivered via the femoral artery, temporarily inflating a soft balloon in the descending aorta to redirect blood flow towards the upper body. The objective of this study is to investigate the feasibility of the NEURESCUE device as an adjunct to Advanced Cardiac Life Support (ACLS) in adults with cardiac arrest.

Conditions

Cardiac Arrest, Cardiopulmonary Arrest, Cardiovascular Diseases

Study Overview

Study Details

Study overview

The NEURESCUE device is the first intelligent catheter for aortic balloon occlusion, an emergency technique that supercharges blood flow to the heart and brain within one minute from deployment. The catheter-based device is delivered via the femoral artery, temporarily inflating a soft balloon in the descending aorta to redirect blood flow towards the upper body. The objective of this study is to investigate the feasibility of the NEURESCUE device as an adjunct to Advanced Cardiac Life Support (ACLS) in adults with cardiac arrest.

A Feasibility Study of the NEURESCUE Device as an Adjunct to In-Hospital Cardiac Arrest

NEURESCUE Device as an Adjunct to In-Hospital Cardiac Arrest (ARISE)

Condition
Cardiac Arrest
Intervention / Treatment

-

Contacts and Locations

Long Beach

Long Beach Medical Center, Long Beach, California, United States, 90806

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Age ≥18 and ≤80 years
  • 2. CPR initiated within 7 min of presumed arrest
  • 3. 8 min of continuous ACLS without ROSC
  • 1. Traumatic cardiac arrest
  • 2. Intraoperative cardiac arrest
  • 3. Known pregnancy
  • 4. Known terminal disease
  • 5. Known do-not-attempt-CPR order
  • 6. Subjects whose femoral arterial access site cannot accommodate an 8 Fr introducer sheath
  • 7. Subjects currently on mechanical circulatory support

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

neurescue,

David Shavelle, M.D., PRINCIPAL_INVESTIGATOR, Long Beach Medical Center

Study Record Dates

2023-07